P29: Skin Substitutes — predatory pricing, distribution, and utilization analysis
First practical analytical use of the stack platform.
Testable hypothesis: certain distributors, products, geographies, and care settings are softer or harder targets for predatory use, distribution, and pricing of skin substitutes.
Data: CMS ASP files (all years since inception), CCLF/synthetic claims, PubMed literature, grey literature (OIG, CMS rules, court filings), enforcement actions.
Key cases: USA v. Jenson et al. (S.D. Tex. 4:25-cr-00271), USA v. Gehrke & King (D. Ariz.), Vohra Wound Physicians (S.D. Fla.).
Deliverables: Zotero evidence base, marimo notebooks, manuscript-ready write-ups.
No due date
90% Completed
